Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Operating Leases (2022 - 2026)

Updated

Analysis

Rallybio (RLYB) Operating Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rallybio 84.05 Mn -201.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 55,000.00
Dec 31, 2025 82,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 116,000.00
Jun 30, 2024 58,000.00
Mar 31, 2024 116,000.00
Dec 31, 2023 173,000.00
Sep 30, 2023 211,000.00
Jun 30, 2023 266,000.00
Mar 31, 2023 321,000.00
Dec 31, 2022 374,000.00
Sep 30, 2022 428,000.00
Jun 30, 2022 478,000.00
Mar 31, 2022 517,000.00
API Access

Rallybio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RLYB&period=max&api_key=YOUR_API_KEY